(Q71836206)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7597123%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

Effects of the CCKB antagonist L-365, 260 on benzodiazepine withdrawal-induced hypophagia in rats (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7597123%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7597123

4 June 2024

author name string

A. J. Goudie

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7597123

4 June 2024

M. J. Leathley

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7597123

4 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7597123

4 June 2024

publication date

1 March 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7597123%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

21 October 2019

http://link.springer.com/content/pdf/10.1007/BF02245250.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/BF02245250

http://link.springer.com/article/10.1007/BF02245250/fulltext.html

4 June 2024

1 reference

https://api.crossref.org/works/10.1007/BF02245250

http://link.springer.com/content/pdf/10.1007/BF02245250

4 June 2024

1 reference

https://api.crossref.org/works/10.1007/BF02245250

4 June 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7597123%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

118

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7597123%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7597123%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

57-64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7597123%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf02245250

21 October 2019

exact match

0 references

cites work

Benzodiazepines antagonize cholecystokinin-induced activation of rat hippocampal neurones

1 reference

12 December 2020

The CCK-B antagonist LY288513 blocks effects of diazepam withdrawal on auditory startle.

1 reference

12 December 2020

Cholecystokinin antagonists

1 reference

12 December 2020

The effects of umespirone as a potential anxiolytic and antipsychotic agent

1 reference

12 December 2020

Conflicting evidence regarding the efficacy of ondansetron in benzodiazepine withdrawal.

1 reference

12 December 2020

Anxiogenic-like action of caerulein, a CCK-8 receptor agonist, in the mouse: influence of acute and subchronic diazepam treatment

1 reference

12 December 2020

A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260

1 reference

12 December 2020

Low but not high doses of buspirone reduce the anxiogenic effects of diazepam withdrawal

1 reference

12 December 2020

Long-term diazepam treatment produces changes in cholecystokinin receptor binding in rat brain.

1 reference

12 December 2020

Effects of the 5-HT3 antagonist GR38032F (ondansetron) on benzodiazepine withdrawal in rats

1 reference

12 December 2020

Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity

1 reference

12 December 2020

The effects of ondansetron (GR38032F) in rats and mice treated subchronically with diazepam.

1 reference

12 December 2020

The effect of ketotifen in rodent models of anxiety and on the behavioural consequences of withdrawing from treatment with drugs of abuse.

1 reference

12 December 2020

Rats with anxious or non-anxious type of exploratory behaviour differ in their brain CCK-8 and benzodiazepine receptor characteristics.

1 reference

12 December 2020

Increased 5-HT release mediates the anxiogenic response during benzodiazepine withdrawal: a review of supporting neurochemical and behavioural evidence

1 reference

12 December 2020

Postponement of satiety by blockade of brain cholecystokinin (CCK-B) receptors

1 reference

12 December 2020

The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist

1 reference

12 December 2020

Evaluation of the dependence potential of the selective 5-H1A agonist ipsapirone in rats and of its effects on benzodiazepine withdrawal

1 reference

12 December 2020

Assessment of the benzodiazepine-like dependence potential in rats of the putative 5-HT(1A) agonist anxiolytic S-20499

1 reference

12 December 2020

Effects of the 5HT(1A) agonist anxiolytic gepirone on benzodiazepine withdrawal signs in rats

1 reference

12 December 2020

Evidence for an involvement of the brain cholecystokinin B receptor in anxiety

1 reference

12 December 2020

The antagonism of benzodiazepine withdrawal effects by the selective cholecystokininB receptor antagonist CI-988

1 reference

12 December 2020

Evidence for a dissociation between benzodiazepine withdrawal signs.

1 reference

12 December 2020

Cholecystokinin and anxiety

1 reference

12 December 2020

Actions of ritanserin, a 5-HT(2/1C) antagonist, in benzodiazepine-dependent rats

1 reference

12 December 2020

Profile of action of a novel 5-hydroxytryptamine1A receptor ligand E-4424 to inhibit aversive behavior in the mouse, rat and marmoset

1 reference

12 December 2020

Effects of the 5-HT3 antagonist ICS 205-930 on benzodiazepine withdrawal signs in rats

1 reference

12 December 2020

Effects of captopril and SQ29,852 on anxiety-related behaviours in rodent and marmoset.

1 reference

12 December 2020

Differential profile of the CCKB receptor antagonist CI-988 and diazepam in the four-plate test.

1 reference

12 December 2020

Effects of the 5-HT3 antagonist ondansetron on benzodiazepine-induced operant behavioural dependence in rats.

1 reference

12 December 2020

The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat

1 reference

12 December 2020

Diazepam withdrawal responses measured in the social interaction test of anxiety and their reversal by baclofen

1 reference

12 December 2020

Evaluation of the effects of PD 134308 (CI-988), A CCK-B antagonist, on the punished responding of squirrel monkeys

1 reference

12 December 2020

Reversal of increased anxiety during benzodiazepine withdrawal: evidence for an anxiogenic endogenous ligand for the benzodiazepine receptor

1 reference

12 December 2020

Ritanserin overcomes exploratory inhibition induced by cocaine withdrawal.

1 reference

12 December 2020

Ethanol- and diazepam-withdrawal hyperlocomotion is not due to 5-HT3 receptor stimulation.

1 reference

12 December 2020

Assessment of the dependence potential of the potent high-efficacy 5-HT1A agonist S-14506 in rats

1 reference

12 December 2020

Diazepam withdrawal: effects of diazepam and gepirone on acoustic startle-induced 22 kHz ultrasonic vocalizations.

1 reference

12 December 2020

'Anxiolytic' effect of CCK-antagonists on plus-maze behavior in mice.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02245250

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7597123%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference